© Reuters. FILE PHOTO: Vials labelled “VACCINE Coronavirus COVID-19” and a syringe are seen in front of a displayed Pfizer logo in this illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration/
NEW YORK (Reuters) – Pfizer Inc (NYSE:) expects to charge about $110 to $130 per dose for its COVID-19 vaccine after the United States government’s current program expires, Pfizer executive Angela Lukin said on a call with analysts.
Lukin said she expects the vaccine will be made available with no co-pay to people who have private insurance or government paid insurance.
The U.S. government currently provides the vaccine for free to all but pays about $30 per dose to Pfizer and German partner BioNTech SE (NASDAQ:). In 2023, the market is expected to move to private insurance after the U.S. public health emergency expires.
Be the first to comment